Skip to content
Home/Companies/MedTech/Vernacare
VE

Vernacare

MedTech·UK·Exited 2020·Held 5yr

Vernacare is a healthcare company, headquartered in United Kingdom.

Entry
2015
Hold
5yr
Exit
2020
Est. EV
–

Who owns Vernacare?

Vernacare was owned by Palatine Private Equity through Palatine Buyout Fund III (2015 vintage) from 2015 to 2020, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Palatine Private Equity
Investor
Palatine Private Equity
Palatine Buyout Fund III · 2015 · Buyout

Key facts

HQUnited Kingdom
SectorHealthcare
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2020

More from Palatine Buyout Fund III

Other portfolio companies in the same fund.

Acora
Exited 2022
IT ServicesUK· 2020
to
Direct Tyre Management (DTM)
Exited 2024
Business ServicesUK· 2020
to
Lucion Services
Active
Business ServicesUK· 2019
Suntera Global
Exited 2025
FinancialsUK· 2019
to
CET
Exited 2021
InsurTechUK· 2018
to
CTS
Exited 2022
Business ServicesUK· 2018
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings